Three-Year Outcomes of Contemporary Left Main Coronary Intervention in Patients With and Without Acute Coronary

Yoshinobu Murasato1, Kensaku Higashi2, Hiroshi Sugino3

  • 1Department of Cardiology, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan.

Insights

Patients with acute coronary syndrome (ACS) undergoing left main percutaneous coronary intervention (LM-PCI) face higher early mortality but similar long-term outcomes compared to those without ACS. Intracoronary imaging use was routine in this real-world study.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Clinical Outcomes Research

Background:

  • Left main percutaneous coronary intervention (LM-PCI) is a common treatment for left main coronary artery disease.
  • Real-world data on long-term outcomes after LM-PCI, particularly comparing patients with and without acute coronary syndrome (ACS), are crucial.
  • Intracoronary imaging guidance is increasingly utilized in LM-PCI procedures.

Purpose of the Study:

  • To evaluate three-year clinical outcomes after contemporary LM-PCI in patients with and without ACS.
  • To identify predictors of major adverse cardiac and cerebrovascular events (MACCEs) in both patient groups.
  • To assess the impact of routine intracoronary imaging guidance on LM-PCI outcomes.

Main Methods:

  • A real-world cohort of 758 consecutive patients undergoing LM-PCI for unprotected de novo lesions was analyzed.
  • Patients were categorized into ACS (n=241) and non-ACS (n=516) groups.
  • Three-year MACCEs (all-cause mortality, revascularization, myocardial infarction, cerebrovascular events) were compared, with routine intracoronary imaging guidance used in 97.6% of cases.

Main Results:

  • Patients with ACS had higher rates of bifurcation lesions, cardiogenic shock, and mechanical circulatory support (MCS) use.
  • Three-year MACCE (40.7% vs. 28.5%) and mortality (25.8% vs. 10.2%) were significantly higher in the ACS group, primarily due to early mortality.
  • After the initial 30 days, revascularization rates were similar between groups (13.4% vs. 15.8%). Predictors for MACCE varied between ACS and non-ACS groups.

Conclusions:

  • Contemporary LM-PCI in patients presenting with ACS is associated with worse three-year outcomes, mainly driven by early mortality.
  • Beyond the early phase, longer-term outcomes, including the need for revascularization, appear comparable between ACS and non-ACS presentations.
  • The study highlights the importance of intracoronary imaging in achieving low rates of adverse events like stent thrombosis and target lesion revascularization.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
440
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
414
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
695
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
1.1K
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.6K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
398